REQUEST A DEMO
Total
USD $0.00
Search more companies

Pro Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pro Laboratories Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pro Laboratories Private Limited is based in India. The head office is in Indore. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on February 15, 2005. In 2024, the company reported a net sales revenue increase of 30.79%. A negative growth of 8.62% was recorded in its total assets. In, 2024, the company’s net profit margin increased by 0.48%.

Legal Address
Plot No. 162, Sanwer Road Sector - D, Industrial Estate
Indore; Madhya Pradesh; Postal Code: 452015

Contact Details: Purchase the Pro Laboratories Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Pro Laboratories Private Limited report to view the information.
Financial Auditors:
Purchase the Pro Laboratories Private Limited report to view the information.
Incorporation Date:
February 15, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
12.5%
Subsidiaries
Pro-Pharma Care Private Limited
100%
Company Performance
Financial values in the chart are available after Pro Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
30.79%
Total Operating Revenue
30.53%
Operating Profit
80.47%
EBITDA
64.35%
Net Profit/Loss for the Period
77.49%
Total Assets
-8.62%
Total Equity
4.64%
Operating Profit Margin
0.82%
Net Profit Margin
0.48%
Return on Equity (ROE)
1.82%
Debt / Equity
19.17%
Quick Ratio
0.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?